Skip to main content
SpringerLink
Log in

Alendronic acid best bet for new German screen-and-treat strategy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mueller D, Weyler E, Gandjour A.Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis. PharmacoEconomics 26: 513-536, No. 6, 2008

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid best bet for new German screen-and-treat strategy. Pharmacoecon. Outcomes News 554, 6 (2008). https://doi.org/10.2165/00151234-200805540-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805540-00012

Keywords

Search

Navigation